Stevanato Group S.p.A. logo

Stevanato Group S.p.A. (STVN) Financials

NYSE NYSE:STVN

Market Cap

8.44B

Total Revenue

983.70M

Gross Profit

319.80M

Operating Income

152.58M

Net Income

143.00M

Metric2019202020212022
536,539,000662,037,000843,900,000983,700,000
398,518,000467,861,000578,500,000663,900,000
138,021,000194,176,000265,400,000319,800,000
7,826,00017,390,00029,600,00034,400,000
26,144,00020,044,00020,400,00026,100,000
50,568,00058,863,00062,500,00085,700,000
76,712,00078,907,00082,900,000111,800,000
75,801,00091,067,000103,100,000127,400,000
62,220,000103,109,000128,118,000152,577,000
-7,506,000-6,830,00037,582,00035,023,000
108,436,000157,863,000184,500,000217,400,000
46,216,00054,754,00056,382,00064,823,000
175,000372,00021,700,00025,000,000
5,606,0005,994,00018,800,00029,800,000
54,714,00096,279,000165,700,000187,600,000
16,007,00017,682,00031,400,00044,600,000
39,201,00078,513,000134,300,000143,000,000
0.130.270.530.54
0.130.270.530.54
294,827,240294,827,240252,670,872264,699,481
294,827,240294,827,240252,690,321264,701,062
474,319,000558,928,000681,600,000791,300,000
-8,737,000-5,230,000-9,400,000-18,800,000

Key Facts

Industry

Medical Instruments & Supplies

Sector

Healthcare

Headquarters

Piombino Dese, PD, IT

CEO

Mr. Franco Moro

Employees

5260

About the Company

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.